The common antidepressant fluvoxamine significantly reduces fatigue and improves quality of life for patients suffering from long COVID.

WEDNESDAY, April 1, 2026 — A common antidepressant appears to help reduce fatigue in people living with long COVID, a new study...

THURSDAY, April 2, 2026 -- Outcomes for acute, intermediate-risk pulmonary embolism (PE) are better with ultrasound-facilitated, catheter-directed...

THURSDAY, April 2, 2026 -- Outcomes for acute, intermediate-risk pulmonary embolism (PE) are better with ultrasound-facilitated, catheter-directed...

Fluvoxamine, a common and affordable antidepressant, significantly reduces bmedlinkpersistent fatigue/medlink and debilitating lethargic symptoms/b

A new variant of COVID-19 is spreading across the U.S., health officials say. At least 23 countries have reported the SARS-CoV-2 BA.3.2 variant as of...

FRIDAY, April 3, 2026 -- Once-daily oral zasocitinib (TAK-279), an oral tyrosine kinase 2 (TYK2) inhibitor, provides a durable response in adults...

THURSDAY, April 2, 2026 -- For infants with early critical bronchiolitis, endotracheal poractant alfa does not reduce the duration of invasive...

THURSDAY, April 2, 2026 -- For infants with early critical bronchiolitis, endotracheal poractant alfa does not reduce the duration of invasive...

WEDNESDAY, April 1, 2026 — A common antidepressant appears to help reduce fatigue in people living with long COVID, a new study says.Fluvoxamine...